Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ————— — Research & development ————— — Operating income 754 M646 M830 M-24 M828 M 2.28 B Non-Operating Income, Total -214 M-240 M-220 M27 M-224 M -657 M Interest expense, net of interest capitalized 250 M257 M261 M264 M272 M 1.05 B Non-Operating Income, excl. Interest Expenses -250 M-281 M-261 M-11 M-272 M -825 M Unusual income/expense 36 M41 M41 M38 M48 M 168 M Pretax income 540 M406 M610 M3 M604 M 1.62 B Equity in earnings 0000— — Taxes 126 M88 M78 M-4 M138 M 300 M Non-controlling/minority interest 54 M50 M91 M56 M61 M 258 M After tax other income/expense ————— — Net income before discontinued operations 360 M268 M441 M-49 M405 M 1.06 B Discontinued operations ————— — Net income 360 M268 M441 M-49 M405 M 1.06 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 360 M268 M441 M-49 M405 M 1.06 B Basic earnings per share (Basic EPS) 0.620.460.76-0.070.7 1.85 Diluted earnings per share (Diluted EPS) 0.620.460.76-0.080.7 1.84 Average basic shares outstanding 577 M577 M577 M577 M578 M — Diluted shares outstanding 578 M578 M578 M578 M580 M — EBITDA 1.17 B1.06 B1.25 B397 M1.25 B 3.95 B EBIT 754 M646 M830 M-24 M828 M 2.28 B Cost of revenue 1.18 B1.16 B1.14 B1.29 B1.62 B 5.21 B Other cost of goods sold 149 M168 M163 M172 M161 M 664 M Depreciation & amortization (cash flow) 411 M415 M417 M421 M421 M 1.67 B